Skip to main content Back to Top
Advertisement

7/5/2022

3% and 5% Sodium Chloride Large Volume Injection

Products Affected - Description

    • 5% Sodium Chloride, BBraun, 500 mL bag, 24 count, NDC 00264-7806-10
    • 5% Sodium Chloride, Baxter, 500 mL bag, 24 count, NDC 00338-0056-03
    • Sodium Chloride, BBraun, 3%, 500 mL bag, 24 count, NDC 00264-7805-10
    • Sodium Chloride, Baxter, 3% 500 mL bag, 24 count, NDC 00338-0054-03
    • Sodium Chloride, Fresenius Kabi, 3% 500 mL bag, 24 count, NDC 63323-0530-75

Reason for the Shortage

    • Baxter did not provide a reason for the shortage.
    • BBraun did not provide a reason for the shortage.
    • Fresenius Kabi did not provide a reason for the shortage.

Available Products

    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Baxter has 3% sodium chloride 500 mL bags and 5% sodium chloride 500 mL bags on allocation.
    • BBraun has 3% sodium chloride 500 mL bags and 5% sodium chloride 500 mL bags on allocation.
    • Fresenius Kabi has 3% sodium chloride 500 mL bags on backorder and the company estimates a release date of early- to mid-August 2022.

Updated

Updated July 5, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. Created April 19, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.